<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:27:18Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:2000912" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:2000912</identifier><datestamp>2007-10-05</datestamp><setSpec>bmcimm</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://dtd.nlm.nih.gov/ns/archiving/2.3/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://dtd.nlm.nih.gov/ns/archiving/2.3/ https://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Immunol</journal-id>
      <journal-title>BMC Immunology</journal-title>
      <issn pub-type="epub">1471-2172</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC2000912</article-id>
      <article-id pub-id-type="pmcid">PMC2000912</article-id>
      <article-id pub-id-type="pmc-uid">2000912</article-id>
      <article-id pub-id-type="pmid">17678538</article-id>
      <article-id pub-id-type="publisher-id">1471-2172-8-12</article-id>
      <article-id pub-id-type="pmid">17678538</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2172-8-12</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>CD8Î± is expressed by human monocytes and enhances FcÎ³R-dependent responses</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" contrib-type="author">
          <name>
            <surname>Gibbings</surname>
            <given-names>Derrick J</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>gibbings@ualberta.ca</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Marcet-Palacios</surname>
            <given-names>Marcelo</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>marcelo@ualberta.ca</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Sekar</surname>
            <given-names>Yokananth</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>yokananth@ualberta.ca</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Ng</surname>
            <given-names>Marcus CY</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>marcusn@ualberta.ca</email>
        </contrib>
        <contrib id="A5" corresp="yes" contrib-type="author">
          <name>
            <surname>Befus</surname>
            <given-names>A Dean</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>dean.befus@ualberta.ca</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Pulmonary Research Group, Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Canada</aff>
      <pub-date pub-type="collection">
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>1</day>
        <month>8</month>
        <year>2007</year>
      </pub-date>
      <volume>8</volume>
      <fpage>12</fpage>
      <lpage>12</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2172/8/12"/>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>2</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>1</day>
          <month>8</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â© 2007 Gibbings et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2007</copyright-year>
        <copyright-holder>Gibbings et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Gibbings
               J
               Derrick
               
               gibbings@ualberta.ca
            </dc:author><dc:title>
            CD8&#x003b1; is expressed by human monocytes and enhances Fc&#x003b3;R-dependent responses
         </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Immunology 8(1): 12-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2172(2007)8:1&#x0003c;12&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2172</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>CD8Î± enhances the responses of antigen-specific CTL activated through TCR through binding MHC class I, favoring lipid raft partitioning of TCR, and inducing intracellular signaling. CD8Î± is also found on dendritic cells and rat macrophages, but whether CD8Î± enhances responses of a partner receptor, like TCR, to activate these cells is not known. TCR and FcR, use analogous or occasionally interchangeable signaling mechanisms suggesting the possibility that CD8Î± co-activates FcR responses. Interestingly, CD8Î±+ monocytes are often associated with rat models of disease involving immune-complex deposition and FcR-mediated pathology, such as arthritis, glomerulonephritis, ischaemia, and tumors. While rat macrophages have been shown to express CD8Î± evidence for CD8Î± expression by mouse or human monocytes or macrophages was incomplete.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>We detected CD8Î±, but not CD8Î² on human monocytes and the monocytic cell line THP-1 by flow cytometry. Reactivity of anti-CD8Î± mAb with monocytes is at least partly independent of FcR as anti-CD8Î± mAb detect CD8Î± by western blot and inhibit binding of MHC class I tetramers. CD8Î± mRNA is also found in monocytes and THP-1 suggesting CD8Î± is synthesized by monocytes and not acquired from other CD8Î±+ cell types. Interestingly, CD8Î± from monocytes and blood T cells presented distinguishable patterns by 2-D electrophoresis. Anti-CD8Î± mAb alone did not activate monocyte TNF release. In comparison, TNF release by human monocytes stimulated in a FcR-dependent manner with immune-complexes was enhanced by inclusion of anti-CD8Î± mAb in immune-complexes.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Human monocytes express CD8Î±. Co-engagement of CD8Î± and FcR enhances monocyte TNF release, suggesting FcR may be a novel partner receptor for CD8Î± on innate immune cells.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>CD8Î± is a surface glycoprotein typically found on a subpopulation of CTL [<xref ref-type="bibr" rid="B1">1</xref>]. CD8Î± enhances responses instigated through the TCR by binding MHC class I and signaling through the src kinase lck and the adaptor protein Linker for Activation of T cells (LAT) [<xref ref-type="bibr" rid="B2">2</xref>]. The classical co-receptor model of CD8 suggests CD8 enhances CTL activation by binding the same MHC class I-peptide as TCR [<xref ref-type="bibr" rid="B3">3</xref>]. Other evidence suggests CD8 is recruited to the site of T cell activation [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. and can enhance T cell responses even when it does not bind at detectable levels to the same MHC class I-peptide as TCR (e.g. CD8 enhances activation of T cells with an MHC class II specific TCR [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>]).</p>
      <p>CD8 on T cells co-activates responses initiated by TCR, but no such co-activating role has been described for CD8 on other CD8+ cells like dendritic cells [<xref ref-type="bibr" rid="B8">8</xref>], NK cells [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]., mast cells [<xref ref-type="bibr" rid="B11">11</xref>] or macrophages (MÏ) [<xref ref-type="bibr" rid="B12">12</xref>]. Interestingly, the FcÎ³ chain, a component of several FcR [<xref ref-type="bibr" rid="B13">13</xref>], NK receptors [<xref ref-type="bibr" rid="B14">14</xref>], and ILT1 [<xref ref-type="bibr" rid="B15">15</xref>] can substitute for CD3Î¶ in TCR expression [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>].; signaling [<xref ref-type="bibr" rid="B18">18</xref>] and T cell activation [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>] Reciprocally, CD3Î¶ can substitute for FcÎ³ in FcR signaling [<xref ref-type="bibr" rid="B21">21</xref>]. FcÎ³ chain is an ancestral homologue of the CD3Î¶ chain [<xref ref-type="bibr" rid="B22">22</xref>]. Furthermore, CD3Î¶-/-Î·-/- mice use FcÎ³ in TCR signaling and CD8-dependent CTL cytotoxicity [<xref ref-type="bibr" rid="B19">19</xref>], strongly suggesting CD8 can function with FcÎ³ in the absence of CD3Î¶ or Î·. In fact, human but not mouse mature T cells often express Syk and FcÎ³ alongside ZAP-70 and CD3Î¶ and in at least some mature effector T cells Syk and FcÎ³ replace ZAP-70 and CD3Î¶ in TCR signaling [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]</p>
      <p>The cell types that express CD8Î± differ among mice, rats and humans. While human [<xref ref-type="bibr" rid="B9">9</xref>] and rat NK cells express CD8Î±, mouse NK cells do not [<xref ref-type="bibr" rid="B25">25</xref>]. Rat MÏ express CD8Î± [<xref ref-type="bibr" rid="B12">12</xref>], however, our efforts and those of others to detect CD8Î± protein on mouse monocytes and MÏ have been unsuccessful [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. A portion of CD8Î± and all the CD8Î² found on mouse dendritic cells is derived from T cells [<xref ref-type="bibr" rid="B28">28</xref>]. As transfer of transmembrane proteins between cells is frequently detected, like CD8 in the case above, it is necessary to determine the source and functionality of CD8Î± when it is detected on a new cell type or in a new species. Since this study was started, two studies identified binding of anti-CD8Î± mAb at high levels to a small percentage of human monocytes during immune responses [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>] Unfortunately neither study queried whether lower levels of CD8Î± were constitutively found on monocytes, demonstrated the cellular origin of the CD8Î± found on monocytes, or demonstrated a function for CD8Î± on monocytes.</p>
      <p>In this report, we provide evidence that human monocytes express CD8Î± and that CD8Î± can enhance responses mediated through FcR.</p>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>CD8Î± and not CD8Î² is present on human peripheral blood monocytes</title>
        <p>Performing flow cytometry on PBMC, a subpopulation of lymphocytes (FSC/SSC gated) expressed high levels of CD8Î± and CD8Î², as expected (Figure <xref ref-type="fig" rid="F1">1B</xref>, anti-CD8Î± mAb OKT8 and Figure <xref ref-type="fig" rid="F1">1C</xref>, anti-CD8Î²-dependent mAb 2ST8.5H7). Six anti-CD8Î± mAb also bound monocytes at levels greater than three times the geometric mean of isotype mAb (Figure <xref ref-type="fig" rid="F1">1B</xref>, gated for analysis by expression of high levels of CD14 [<xref ref-type="bibr" rid="B31">31</xref>] and characteristic FSC/SSC scatter [Figure <xref ref-type="fig" rid="F1">1A</xref>]). The monocytic cell line THP-1 bound CD8Î± mAb at levels comparable to blood monocytes (data not shown). CD8Î² was not detected on monocytes with mAb 2ST8.5H7 (Figure <xref ref-type="fig" rid="F1">1C</xref>) or 5F2 (not shown), suggesting they do not express CD8Î±Î² (mAb 2ST8.5H7) or putative CD8Î²Î² dimers (mAb 5F2) [<xref ref-type="bibr" rid="B32">32</xref>]. Accordingly, mRNA for CD8Î² was detected in total PBMC containing CD8Î±Î²+ T cells, but not in highly enriched monocytes (data not shown).</p>
        <fig position="float" id="F1">
          <label>Figure 1</label>
          <caption>
            <p>CD8Î± is detected by flow cytometry on CD14<sup>hi </sup>monocytes from human peripheral blood. Anti-CD8Î± mAb bind monocytes by flow cytometry. <italic>A</italic>, Monocytes were gated by characteristic FSC/SSC scatter (left panel) and expression of high levels of CD14 (right panel) for all flow cytometry studies in this article. <italic>B</italic>, A population of lymphocytes, gated by characteristic FSC/SSC scatter, bind high levels of anti-CD8Î±. Blood monocytes gated in <italic>A</italic>, bind anti-CD8Î± mAb. Geometric means of monoclonal antibody binding are shown. Results are representative of five experiments. <italic>C</italic>, Anti-CD8Î² mAb bind lymphocytes but not monocytes.</p>
          </caption>
          <graphic xlink:href="1471-2172-8-12-1"/>
        </fig>
      </sec>
      <sec>
        <title>CD64 does not contribute to anti-CD8Î± mAb binding to monocytes</title>
        <p>To examine whether Fc receptors contributed to binding of anti-CD8Î± mAb to monocytes we first tested the contribution of CD64, the high affinity FcR. CD64 binds immunoglobulin with 100-fold or more the affinity of other FcÎ³R [<xref ref-type="bibr" rid="B33">33</xref>], is the only FcÎ³R that binds monomeric Ig [<xref ref-type="bibr" rid="B34">34</xref>] and preferentially binds mouse IgG2a antibodies compared to mouse IgG1 [<xref ref-type="bibr" rid="B35">35</xref>]. Accordingly, as human monocytes express significant amounts of CD64 [<xref ref-type="bibr" rid="B31">31</xref>] mouse IgG2a has a 100â1000 fold higher affinity for binding human monocytes than mouse IgG1 [<xref ref-type="bibr" rid="B36">36</xref>]. Incubating monocytes with human Ig preparations [<xref ref-type="bibr" rid="B37">37</xref>] (not shown) or a mAb which blocks binding of Ig to CD64 (clone 10.1) [<xref ref-type="bibr" rid="B38">38</xref>] slightly decreased binding of IgG2a isotype control mAb (11â27% geometric mean) and did not decrease binding of anti-CD8Î± mAb (Figure <xref ref-type="fig" rid="F2">2A</xref>).</p>
        <fig position="float" id="F2">
          <label>Figure 2</label>
          <caption>
            <p>Binding of anti-CD8Î± mAb to monocytes is independent of FcR. <italic>A</italic>, Blockade of Ig binding to CD64 with anti-CD64 mAb decreases binding of isotype mAb but not anti-CD8Î± mAb to monocytes. Bracketed numbers are geometric means of indicated peaks. <italic>B</italic>, Western blot with anti-CD8Î± D9 detects a 32 kDa protein as expected for CD8Î± in THP-1, peripheral blood lymphocytes, thymus lysate, peripheral blood monocytes (&gt;99%), GM-CSF differentiated MÏ, PBMC, thymus, and a CTL clone but not in the lung epithelial line A549 (CD8Î± negative control). Right, anti-CD8Î± mAb B9.11 detects a 32 kDa protein as expected for CD8Î± in THP-1 and peripheral blood lymphocytes. 1â1.5 Ã 10<sup>6 </sup>cell equivalents were loaded in each lane.</p>
          </caption>
          <graphic xlink:href="1471-2172-8-12-2"/>
        </fig>
      </sec>
      <sec>
        <title>CD8Î± is detected in monocytic cell line and &gt;99% human monocytes independent of FcR</title>
        <p>To test whether CD8Î± is detected in human monocytes by a method generally acknowledged to be independent of FcÎ³R binding to IgG we performed western blot for CD8Î±. Proteins at 32 kDa, consistent with CD8Î± were detected with anti-CD8Î± mAb D9 by western blot (Figure <xref ref-type="fig" rid="F2">2B</xref>) of thymus lysate, blood lymphocytes, immature monocytes (THP-1), mature <italic>ex vivo </italic>monocytes (&gt;99% CD14<sup>hi</sup>, CD3Î¶[-ve], enrichment Figure <xref ref-type="fig" rid="F4">4A</xref>), and MÏ differentiated with GM-CSF from blood monocytes, but not in lung epithelial cells (A549, negative control). Similarly, a 32 kDa protein was found by western blot with anti-CD8Î± mAb B9.11 in PBMC and THP-1 (Figure <xref ref-type="fig" rid="F2">2B</xref>). These data suggest that anti-CD8Î± mAb binding to monocytes is due to the presence of CD8Î± protein and not non-specific binding to FcÎ³R.</p>
        <fig position="float" id="F4">
          <label>Figure 4</label>
          <caption>
            <p>Human monocytes express CD8Î± mRNA. Right, purification of monocytes (&gt;99% CD14<sup>hi </sup>after sorting) was also confirmed by attempting to detect the T and NK cell transcript, CD3Î¶, in monocytes. A 293 bp fragment of CD3Î¶ mRNA was detected in PBMC, containing T cells, but not monocytes, the monocytic line THP-1, or lung epithelial cells (A549) after 50 cycles. <italic>B</italic>, A 379 bp CD8Î± mRNA fragment was detected by RT-PCR in THP-1, &gt;99% CD14<sup>hi </sup>monocytes, PBMC, but not in a lung epithelial cell line, (A549) using intron-spanning primers, and 35 cycles of cDNA amplification. Detection of Î²-actin mRNA confirmed RNA extraction and RT-PCR was performed successfully.</p>
          </caption>
          <graphic xlink:href="1471-2172-8-12-4"/>
        </fig>
      </sec>
      <sec>
        <title>Peripheral localization of CD8Î± on human monocytes: confocal microscopy</title>
        <p>To confirm the expected localization of CD8Î± to the cell periphery on monocytes we performed two-color confocal microscopy of permeabilized PBMC (Figure <xref ref-type="fig" rid="F3">3</xref>). All anti-CD8Î± mAb detected CD8Î± at the periphery of CD14<sup>hi </sup>monocytes and some CD3<sup>hi </sup>T cells (Figure <xref ref-type="fig" rid="F3">3BâE</xref> mAb B9.11 is shown, and is representative of results obtained with LT8, OKT8, 32-M4, 51.1, and Nu-Ts/c). CD8Î± was also observed intracellularly in some monocytes with a distribution resembling CD14, suggesting that similar to NK cells [<xref ref-type="bibr" rid="B39">39</xref>] a small proportion of CD8Î± may be found intracellularly in monocytes, perhaps in recycling endosomes.</p>
        <fig position="float" id="F3">
          <label>Figure 3</label>
          <caption>
            <p>CD8Î± is detected by confocal microscopy on peripheral blood monocytes and lymphocytes with several anti-CD8Î± mAb. <italic>A</italic>, CD3-FITC and CD14-FITC binding to PBMC (Green). <italic>B-E</italic>, Anti-CD8Î± mAb (<italic>D</italic>, <italic>E</italic>) binding to monocytes and lymphocytes in comparison to isotype mAb (<italic>B</italic>, <italic>C</italic>) (Red). Results are representative of other anti-CD8Î± mAb (OKT8, 51.1, 32-M4, Nu-Ts/c, and B9.11).</p>
          </caption>
          <graphic xlink:href="1471-2172-8-12-3"/>
        </fig>
      </sec>
      <sec>
        <title>Human monocytes express CD8Î± mRNA</title>
        <p>The monocytic cell line THP-1 must synthesize CD8Î± as no other sources of CD8Î± are available (FBS was CD8Î± negative by parallel western blot). In contrast <italic>ex vivo </italic>monocytes may acquire CD8Î± from other CD8Î±+ cells in the body. The presence of CD8Î± mRNA would suggest that monocytes can synthesize the CD8Î± protein associated with them. Due to the sensitivity of RT-PCR for mRNA from contaminating cells, we studied the cultured monocytic line THP-1 in addition to highly enriched monocytes (negative for T cell/NK cell specific CD3Î¶ mRNA, &gt;99% FSC/SSC and CD14<sup>hi </sup>monocytes, Figure <xref ref-type="fig" rid="F4">4A</xref>). CD8Î± mRNA was detected in peripheral blood mononuclear cells (containing CD8Î±+ T cells [positive control]), THP-1 monocytic cell line, and highly purified blood monocytes, but not in a lung epithelial cell line (A549) as expected (Figure <xref ref-type="fig" rid="F4">4B</xref>).</p>
      </sec>
      <sec>
        <title>CD8Î± on monocytes binds MHC class I</title>
        <p>Whatever the eventual cellular derivation of CD8Î± protein found on <italic>ex vivo </italic>monocytes, its ability to function (e.g. bind MHC class I) and impact monocyte responses is practically relevant. We tested whether CD8Î± on human monocytes contributes to monocyte binding to MHC class I. We expected that anti-CD8Î± mAb would not block all tetramer binding to human monocytes because members of the immunoglobulin-like-transcript (ILT/CD85) family (ILT2, 4) expressed by monocytes bind MHC class I tetramers, interact with regions on MHC class I that overlap with CD8Î± and thus compete with CD8Î± for binding of MHC class I [<xref ref-type="bibr" rid="B40">40</xref>].</p>
        <p>Thymocytes from CD8Î² knockout mice bind MHC class I tetramers and overexpression of CD8Î± enhances this CD8-dependent binding [<xref ref-type="bibr" rid="B41">41</xref>], suggesting that despite the heightened ability of CD8Î±Î² (at least in an unsialylated form on thymocytes [<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>]) to bind MHC class I tetramers, CD8Î±Î± is also capable of mediating tetramer binding to T cells.</p>
        <p>HLA-*0201 tetramers bound to nearly all CD14<sup>hi </sup>monocytes (Fig <xref ref-type="fig" rid="F5">5A</xref>). Tetramers complexed with two different peptides bound similarly to monocytes (data not shown). In agreement with others [<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B45">45</xref>]., we found that anti-CD8Î± clone B9.11 inhibited HLA tetramer binding (Figure <xref ref-type="fig" rid="F5">5B</xref>, 11.6%). Another anti-CD8Î± clone, D9, also inhibited tetramer binding (Figure <xref ref-type="fig" rid="F5">5B</xref>, 18.6%, p &lt; 0.05). Finally, tetramer binding was not affected by clone 32-M4 (despite its ability to bind CD8Î± on monocytes), or isotype control mAb (Figure <xref ref-type="fig" rid="F5">5B</xref>). Other studies of MHC class I tetramer binding to CD8Î± using several anti-CD8Î± mAb have also shown that tetramer binding may be unaffected, inhibited or enhanced by anti-CD8Î± mAb, depending on which anti-CD8Î± clone is used, and TCR affinity [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B47">47</xref>].</p>
        <fig position="float" id="F5">
          <label>Figure 5</label>
          <caption>
            <p>CD8Î± on human peripheral blood monocytes mediates MHC class I binding. <italic>A</italic>, Dark histogram is background fluorescence of CD14<sup>hi </sup>monocytes, light histogram represents binding of PE-labeled tetramers. <italic>B</italic>, Bar graph is pooled results of gated CD14<sup>hi </sup>monocytes from three different donors in separate experiments. Inhibition of tetramer binding is expressed as percent decrease in mean fluorescence intensity of tetramer binding due to pretreatment with anti-CD8Î± mAb compared to isotype mAb (* p &lt; 0.05, non-paired t-test).</p>
          </caption>
          <graphic xlink:href="1471-2172-8-12-5"/>
        </fig>
        <p>While our evidence suggests CD8Î± contributes to MHC class I tetramer binding by human monocytes, the observed dimunition of tetramer binding may be via an effect on the kinetics or stability of tetramer binding to other receptors for MHC class I.</p>
      </sec>
      <sec>
        <title>Fewer Sialylated 34 kDa Versions of CD8Î± are found on Monocytes Compared to T cells</title>
        <p>Previous publications have demonstrated notable differences in immunoprecipitated CD8Î± by 2-D electrophoresis. Some authors detected immunoprecipitated CD8Î± from thymus as restricted spots of pI ~ 6 [<xref ref-type="bibr" rid="B48">48</xref>]. In contrast, others detected immunoprecipitated CD8Î± from blood at numerous spots ranging from pI 6â9.5 [<xref ref-type="bibr" rid="B49">49</xref>], and molecular weights of 32 to 34 kDa [<xref ref-type="bibr" rid="B50">50</xref>]. We tested whether CD8Î± from monocytes in comparison to blood lymphocytes exhibit a distinct pattern of sialylation or other post-translational pattern detectable by 2-D electrophoresis.</p>
        <p>A polyclonal anti-CD8Î± antibody detected discrete spots across 2-D gels from the predicted pI of unglycosylated CD8Î± (~9) to pI 6â7, at Mr from 32â34 kDa (Figure <xref ref-type="fig" rid="F5">5</xref>), as shown by others [<xref ref-type="bibr" rid="B49">49</xref>]. Much of the heterogeneity detected with anti-CD8Î± polyclonal antibody could be eliminated by treatment with neuraminidase, suggesting it is due to sialylation of CD8Î± (Figure <xref ref-type="fig" rid="F6">6A</xref>). Notably, monocytes had less of the sialylated 34 kDa forms of CD8Î± than T cells in samples from three individuals (Figure <xref ref-type="fig" rid="F6">6A</xref>). In contrast, anti-CD8Î± clone D9 detected a single protein spot (32 kDa, ~pI 6), in a pattern similar to that found by others [<xref ref-type="bibr" rid="B48">48</xref>]. To confirm that the protein recognized at 32 kDa pI 6 was CD8Î± we sequenced it by MALDI-QTOF from 2-D gels (see Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>). Neuraminidase treatment diminished but did not eliminate the protein spot recognized by anti-CD8Î± clone D9 and gave rise to faint basic spots similar to those observed with polyclonal anti-CD8Î± antibody after neuraminidase treatment. D9 may preferentially recognize particular glycosylation/sialylation patterns of CD8Î± (Figure <xref ref-type="fig" rid="F6">6B,C</xref>).</p>
        <fig position="float" id="F6">
          <label>Figure 6</label>
          <caption>
            <p>Subtle differences in CD8Î± between monocytes and lymphocytes detected by 2-D electrophoresis. <italic>A</italic>, Western blot with a polyclonal anti-CD8Î± antibody after 2-D electrophoresis of <italic>ex vivo </italic>monocytes and lymphocytes. Cell lysates of lymphocytes and monocytes from one donor were separated by adherence, halved and treated (bottom panels) or not treated (top panels) with neuraminidase before analysis. <italic>B</italic>, Western blot with anti-CD8Î± mAb D9. <italic>C</italic>, Neuraminidase treatment and western blot with D9 of lymphocyte lysate. Results are representative of experiments with three donors.</p>
          </caption>
          <graphic xlink:href="1471-2172-8-12-6"/>
        </fig>
        <p>In our experiments large differences in 2-D electrophoresis patterns for CD8Î± (e.g. between D9 and polyclonal anti-CD8Î± Ab) are due to the specificity of different antibodies recognizing CD8Î±, and not a result of differences in the cell type expressing CD8Î±. Nonetheless, using the same polyclonal antibody, subtle differences in CD8Î± were found between monocytes and lymphocytes by 2-D electrophoresis.</p>
      </sec>
      <sec>
        <title>Anti-CD8Î± mAb amplifies monocyte responses to immune-complexes through FcÎ³R</title>
        <p>TCR and FcR use analogous and sometimes interchangeable signaling mechanisms to activate cells [<xref ref-type="bibr" rid="B20">20</xref>], and CD3Î¶Î·-null mice can use FcÎ³ to reconstitute CD8/TCR-dependent CTL cytotoxicity[<xref ref-type="bibr" rid="B23">23</xref>]. We investigated if CD8Î± on monocytes might be involved in responses to immune-complexes mediated by FcÎ³R. To this end, we used a common immune-complex-FcÎ³R activation system.</p>
        <p>Treatment of monocytes with monomeric non-specific IgG<sub>2a </sub>mAb induced a slight increase in monocyte TNF production (Figure <xref ref-type="fig" rid="F7">7A,B</xref>). This is likely due to the ability of the high affinity FcÎ³R, CD64, found on the majority of monocytes to bind monomeric mouse IgG<sub>2a </sub>[<xref ref-type="bibr" rid="B36">36</xref>]. Monomeric anti-CD8Î± mAb did not increase monocyte TNF production more than control IgG<sub>2a </sub>mAb (Figure <xref ref-type="fig" rid="F7">7A,B</xref>). When monocytes were stimulated with preformed immune-complexes (isotype mAb cross-linked with anti-mouse Ig), CD14<sup>hi </sup>monocytes produced moderate amounts of intracellular TNF (Figure <xref ref-type="fig" rid="F7">7A,B</xref>). Formation of immune-complexes with anti-CD8Î± mAb (32-M4 cross-linked with anti-mouse Ig) rather than isotype mAb, resulted in production of 2-fold more TNF by monocytes (Figure <xref ref-type="fig" rid="F7">7A,B</xref>). Immune-complexes containing anti-CD8Î± mAb D9 did not significantly increase monocyte TNF production above control immune-complexes, indicating that monocyte TNF release is not significantly stimulated by any immune-complex containing a mAb that binds to the monocyte surface. It is not surprising that only one of two anti-CD8Î± mAb enhanced FcÎ³R-dependent responses, because when others have screened several anti-CD8Î± mAb in parallel for effects on CTL cytotoxicity, or CD8-MHC class I binding (see above), the effect ranged from substantial inhibition to no effect depending on the particular anti-CD8Î± mAb clone [<xref ref-type="bibr" rid="B51">51</xref>-<xref ref-type="bibr" rid="B53">53</xref>]</p>
        <fig position="float" id="F7">
          <label>Figure 7</label>
          <caption>
            <p>CD8Î± enhances monocyte TNF production in a FcÎ³R-dependent manner. Monocytes were incubated with anti-CD8Î± or isotype mAb alone or in immune-complexes. Excess Fc fragment was used to block FcÎ³R. TNF production was measured by intracellular flow cytometry after 5 h (gated on CD14<sup>hi </sup>monocytes). <italic>A</italic>. Histograms are representative results. <italic>B</italic>. Bar graph represents average geometric mean of intracellular TNF from four separate experiments with monocytes from different donors. Standard error of the mean is designated by error bars. *: p &lt; 0.05 non-paired t-test. C. CD69 and CD14 regulation induced by immune-complexes (IC) is enhanced by CD8Î± ligation (representative example).</p>
          </caption>
          <graphic xlink:href="1471-2172-8-12-7"/>
        </fig>
        <p>Enhanced activation of monocytes incubated with immune-complexes containing anti-CD8Î± mAb in comparison to immune-complexes with isotype control was also found when TNF release (1376 pg/mL versus 468 pg/mL, p &lt; 0.05 [data not shown]), CD69 upregulation, or CD14 downregulation was measured (Figure <xref ref-type="fig" rid="F7">7C</xref>).</p>
        <p>Blockade of FcR with excess Fc fragments nullified TNF release instigated by isotype and anti-CD8Î± immune-complexes (Figure <xref ref-type="fig" rid="F7">7</xref>), suggesting the immune-complex system used is FcÎ³R-dependent, as expected. As CD8Î± enhancement of TNF production is inhibited by Fc fragments and does not occur with monomeric anti-CD8Î± mAb, the ability of anti-CD8Î± mAb to enhance responses of human monocytes appears to depend on co-engagement of FcR.</p>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>The present study demonstrates expression of CD8Î± by monocytic cells, and suggests that CD8Î±, in addition to co-activating TCR responses may have a previously unacknowledged role in co-activating FcÎ³R responses.</p>
      <p>Previous to the present study no evidence existed to demonstrate that human monocytes synthesized CD8Î±. Human PBMC can appear CD14+/CD8Î±<sup>hi </sup>in HIV infected individuals, but this population is due to acquisition of CD14 from monocytes, by T cells, that are mostly CD8Î±+ [<xref ref-type="bibr" rid="B54">54</xref>,<xref ref-type="bibr" rid="B55">55</xref>]. A similar effect may explain previous claims of CD8Î± on monocytes subsequent to dengue virus infection [<xref ref-type="bibr" rid="B30">30</xref>]. Other studies have demonstrated that macrophages and dendritic cells can acquire CD8Î± from T cells, without themselves synthesizing it [<xref ref-type="bibr" rid="B28">28</xref>]. Thus, the detection of CD8Î± protein on monocytes in other studies [<xref ref-type="bibr" rid="B29">29</xref>] does not demonstrate that CD8Î± is expressed by, or more importantly, functional on monocytes.</p>
      <p>We provide strong evidence that human monocytes constitutively express CD8Î± at low levels. Notably, CD8Î± was observed in monocytes, and the monocytic cell line THP-1 by western blot confirming the presence of CD8Î± in these cells without possible contribution of FcÎ³R. Moreover, detection of CD8Î± mRNA in THP-1, CD8Î± protein on THP-1 and 32 kDa CD8Î± in lysate of continuously cultured THP-1, demonstrates that these monocytic cells must transcribe CD8Î± mRNA and translate CD8Î± protein.</p>
      <p>We find that monocytes have less 34 kDa sialylated forms of CD8Î± compared to T cells. The Mr difference between 32 and 34 kDa forms of CD8Î± may be due to glycosylation other than sialylation [<xref ref-type="bibr" rid="B50">50</xref>] (Figure <xref ref-type="fig" rid="F5">5</xref>), or palmitoylation of CD8Î±)[<xref ref-type="bibr" rid="B56">56</xref>] at three eligible membrane-proximal cysteines [<xref ref-type="bibr" rid="B57">57</xref>]. Monocytes and T cells may express different glycosylation or palmitoylation enzymes that account for predominant accumulation of 32 or 34 kDa CD8Î±. Phosphorylation of CD8Î±, or oxidation of the free cysteine in the CD8Î± Ig-domain may explain pI differences of CD8Î± remaining after neuraminidase treatment. Sialylation of CD8Î± [<xref ref-type="bibr" rid="B58">58</xref>], like CD8Î² [<xref ref-type="bibr" rid="B42">42</xref>], changes during T cell development, and potentially upon T cell activation. Differential sialylation and palmitoylation of CD8 are known to modulate its ability to bind MHC class I and induce T cell activation [<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B59">59</xref>] Unfortunately, we cannot relate the differences in CD8Î± we observe between monocytes and T cells to their comparative ability to bind MHC class I and co-activate signaling.</p>
      <p>The ability of CD8 to enhance T cell responses in a TCR-dependent manner was defined over twenty years ago. Since then, CD8Î± expression by several cell types that lack the TCR such as human NK cells [<xref ref-type="bibr" rid="B9">9</xref>], dendritic cells [<xref ref-type="bibr" rid="B60">60</xref>], rat macrophages [<xref ref-type="bibr" rid="B12">12</xref>] and mast cells [<xref ref-type="bibr" rid="B61">61</xref>] has been established. Some evidence has suggested a role for CD8Î± in apoptosis and survival (e.g. [<xref ref-type="bibr" rid="B39">39</xref>]) however a viable model has not emerged to define when and how CD8Î± activation by its ubiquitous MHC class I ligand may be controlled on these cells that lack the TCR.</p>
      <p>MHC class I-like protein TL, which exhibits a restricted expression pattern and a high binding affinity for mouse CD8Î±Î±, but not CD8Î±Î² [<xref ref-type="bibr" rid="B62">62</xref>] could hypothetically control activation of CD8Î±Î±+ monocytes or dendritic cells. One model has proposed that mouse CD8Î±Î± may downregulate T cell responses and promote generation of memory T cells by binding TL [<xref ref-type="bibr" rid="B63">63</xref>,<xref ref-type="bibr" rid="B64">64</xref>] however, evidence that CD8Î±Î± has a role in generation of memory T cells is controversial [<xref ref-type="bibr" rid="B65">65</xref>-<xref ref-type="bibr" rid="B67">67</xref>]. Similarly, while one study suggests an inhibitory role of CD8Î±Î± on proliferation and cytotoxicity of T cells (but an enhancement of cytokine release) [<xref ref-type="bibr" rid="B68">68</xref>], several studies demonstrate the ability of CD8Î±Î± to enhance T cell cytotoxicity and other responses [<xref ref-type="bibr" rid="B69">69</xref>-<xref ref-type="bibr" rid="B73">73</xref>]. In the absence of a equivalent of TL in humans that binds CD8Î±Î± with high affinity, the applicability of this model to humans is even more problematic.</p>
      <p>Interestingly, some evidence previous to this report suggested CD8 may be able to co-activate responses of FcÎ³R. Many of the components of FcR and TCR signaling are homologous or interchangeable, such as FcÎ³ and CD3Î¶ chain, ZAP-70 and Syk [<xref ref-type="bibr" rid="B74">74</xref>,<xref ref-type="bibr" rid="B75">75</xref>]., or LAT [<xref ref-type="bibr" rid="B76">76</xref>]. For instance, FcÎ³ and CD3Î¶ are conserved ancestral duplicates [<xref ref-type="bibr" rid="B77">77</xref>] that can substitute for each other in activation of mast cells, Î³Î´ or Î±Î² T cells [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B23">23</xref>] LAT binds CD8Î±, and is phosphorylated upon macrophage activation through FcÎ³R [<xref ref-type="bibr" rid="B76">76</xref>] or upon FcÎ³-dependent activation in mast cells and platelets [<xref ref-type="bibr" rid="B78">78</xref>]. A more direct suggestion that CD8 can co-activate FcÎ³-chain dependent signaling through TCR was provided by the demonstration of CD8 involvement in TCR-mediated cytotoxicity in FcÎ³+, CD3Î¶Î·-/- CTL [<xref ref-type="bibr" rid="B19">19</xref>]. What is more, FcÎ³ and Syk are naturally expressed by many mature and immature T cells in humans (less so in mice), and participate in TCR-signaling [<xref ref-type="bibr" rid="B23">23</xref>], suggesting that <italic>in vivo </italic>even on T cells CD8 may have a role in activating FcÎ³ responses[<xref ref-type="bibr" rid="B24">24</xref>]. In sum, reasonable although little acknowledged evidence existed that CD8 participated in FcÎ³ chain-linked responses in T cells. However, no evidence had shown whether CD8 could enhance FcÎ³ chain responses that were not mediated through TCR thereby expanding this model to include possible functions of CD8 on monocytes, NK cells, dendritic cells, or mast cells.</p>
      <p>We and others have previously demonstrated that CD8Î± on rat MÏ and NK cells signals through Syk and src tyrosine kinases [<xref ref-type="bibr" rid="B79">79</xref>], consistent with TCR and FcÎ³R signaling, but in the absence of TCR [<xref ref-type="bibr" rid="B80">80</xref>,<xref ref-type="bibr" rid="B81">81</xref>] Here, we find that anti-CD8Î± mAb enhances TNF production of monocytes exposed to immune complexes in an Fc-dependent manner, mirroring the ability of CD8Î± to enhance T cell activation in a TCR-dependent manner. This evidence suggests CD8Î± enhances FcÎ³R responses, through at least one of several potential mechanisms. In experiments presented here CD8Î± may promote initial contact and binding stability of anti-CD8Î± mAb containing immune-complexes with FcÎ³R. In the same way, CD8Î± may promote binding of FcÎ³R to MHC class I-expressing cells coated with immune-complexes in cancer, viral infection or autoimmune disease. Alternatively, or in addition, signaling through CD8Î± may enhance activation of FcÎ³R signaling in our experiments. While we have not directly demonstrated that CD8Î± signaling enhances FcÎ³R signaling, previous evidence supports this possibility and suggests it merits further investigation. If CD8Î± signaling can enhance FcÎ³R signaling then hypothetically CD8Î± may enhance responses of other receptors that both CD3Î¶ and FcÎ³ can function with such as NKp30, and NKp46 [<xref ref-type="bibr" rid="B14">14</xref>] in NK cells, and FcÎµRI in mast cells [<xref ref-type="bibr" rid="B21">21</xref>].</p>
      <p>Our evidence suggests monocyte responses instigated through immune-complexes and FcR can be amplified by co-engagement of CD8Î±. Interestingly, in rats CD8Î±+ monocytes and MÏ are found at sites of tissue damage in immune-complex mediated glomerulonephritis [<xref ref-type="bibr" rid="B82">82</xref>], arthritis [<xref ref-type="bibr" rid="B83">83</xref>], tumor [<xref ref-type="bibr" rid="B84">84</xref>], experimental allergic encephalomyelitis (a model of multiple sclerosis) [<xref ref-type="bibr" rid="B85">85</xref>], and ischaemia-reperfusion injury [<xref ref-type="bibr" rid="B86">86</xref>]. TNF is an important mediator in many of these diseases [<xref ref-type="bibr" rid="B87">87</xref>,<xref ref-type="bibr" rid="B88">88</xref>] As monocyte TNF production is enhanced by co-activation of CD8Î± and immune-complexes, CD8Î± on monocytes may aggravate some autoimmune and acute inflammatory conditions characterized by tissue deposition of immune-complexes.</p>
      <p>In summary, we find that human monocytes express CD8Î± and that monocyte CD8Î± is differentiable from that on T cells by 2-D electrophoresis. We provide evidence that CD8Î± on monocytes amplifies responses initiated through FcR, suggesting for the first time a co-activator role for CD8 on cells without the TCR.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Antibodies</title>
        <p>Isotype control antibodies were mouse IgG<sub>1 </sub>and IgG<sub>2a </sub>(Sigma, St. Louis, MO), IgG<sub>2a</sub>-FITC, and -PE, (Caltag, Burlingame, CA). Anti-CD8Î± mAb used were: D9 and 32-M4 (Santa Cruz, Santa Cruz, CA) LT8 (Serotec, Raleigh, NC), B9.11 (Beckman-Coulter Canada Inc., Mississauga, ON), and Nu-Ts/c (Nicherei Corp., Tokyo, Japan). Polyclonal anti-human CD8Î± Ab (H160) was obtained from Santa Cruz. Anti-CD8Î± mAb 51.1 (gift of Dr. D. Burshtyn, University of Alberta) and OKT8, and anti-rat MHC class I mAb OX18 (European Collection of Cell Cultures, Salisbury, UK) were purified from hybridoma supernatant by protein G affinity chromatography. Anti-CD8Î²-antibodies were obtained from Beckman-Immunotech (clone 2ST8.5H7-PE, Mississauga, Canada) and Serotec (clone 5F2). Anti-CD3-FITC and anti-CD14-FITC/PE were obtained from Caltag. Anti-mouse Ig-FITC (STAR70) was obtained from Serotec. Anti-CD69 mAb and matching isotype control were obtained from BD Biosciences. Anti-mouse Ig-HRP was purchased from Pierce (Rockford, IL).</p>
      </sec>
      <sec>
        <title>Cell recovery and culture</title>
        <p>The promonocytic cell line THP-1 was maintained in American Type Culture Collection recommended media (RPMI 1640 medium, 2 mM L-glutamine, 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, 1.0 mM sodium pyruvate 0.05 mM 2-mercaptoethanol, and 10% fetal bovine serum [FBS]). CTL clones [<xref ref-type="bibr" rid="B68">68</xref>] were a gift of Dr. Chris Bleackley (University of Alberta).</p>
        <p>Human blood (100 mL) was collected into heparanized tubes. Red blood cells were sedimented by addition of 7 mL 6% dextran (Sigma) in RPMI 1640 per 35 mL blood (0.5 h, room temperature). PBMC were enriched on Ficoll-Paque Plus (Amersham Biosciences, Oakville, ON, Canada) and washed three times in PBS. Monocytes were further enriched by three methods. Greater than 80% enriched monocytes were obtained from a Percoll gradient [<xref ref-type="bibr" rid="B89">89</xref>] for studies of monocyte activation. Monocytes enriched by Percoll were further purified (&gt;99%) by anti-CD14-PE flow sorting for western blot and RT-PCR analysis. MÏ were differentiated from adherent monocytes (1 h, 37 C) with 500 ng/mL GM-CSF (Biosource, Camarillo, CA) for 3 d.</p>
      </sec>
      <sec>
        <title>Flow cytometry</title>
        <p>Cells on ice were blocked with 5% milk, 0.1% bovine serum albumin (BSA) in PBS. In some experiments human Ig (50 Î¼g/mL, Bethyl Laboratories Inc., Montgomery, TX) was used to minimize binding of mAb to FcR. Cells were treated with 10 Î¼g/mL isotype mAb or anti-CD8Î± mAb, washed three times and incubated with anti-mouse Ig-FITC Ab (1/100, STAR70, Serotec). Anti-CD8Î² mAb 2ST8.5H7 directly conjugated to PE was used at 10 Î¼g/mL and compared to IgG2a-PE. Cells were washed three times and incubated with 1/10 normal mouse serum before addition of anti-CD14-FITC (1/50).</p>
        <p>To analyse the contribution of high affinity FcÎ³RI to anti-CD8Î± mAb binding to monocytes, PBMC were pre-incubated for 30 min with anti-CD64 mAb clone 10.1 (10 Î¼g/mL, BioLegend, San Diego, CA), which blocks binding of Ig to CD64 [<xref ref-type="bibr" rid="B38">38</xref>]. Cells were washed and incubated with IgG2a-PE (10 Î¼g/mL, BD Biosciences) or 32-M4-PE (10 Î¼g/mL, Santa Cruz). Cells were washed and data was collected on a FACScan.</p>
        <p>All flow cytometry analysis was performed with WinMDI and CellQuest Pro (BD Biosciences) programs. Monocytes were gated by characteristic FSC/SSC scatter and high expression of CD14.</p>
      </sec>
      <sec>
        <title>Confocal Microscopy</title>
        <p>PBMC were adhered to poly-L-lysine coated coverslips for 0.5 h, fixed with 4% paraformaldehyde (10 min) and permeabilized with 0.1% triton-X-100 in PBS (10 min). Cells were blocked (10% FBS, 3% BSA, 30 min) before staining with anti-CD8Î± mAb (10 Î¼g/mL). Cells were washed three times (5 min, 2 mL PBS) between each reagent. Cells were sequentially incubated with anti-mouse-Ig-rhodamine red (Molecular Probes, Eugene, OR), 1/10 normal mouse serum and anti-CD14-FITC or anti-CD3-FITC (Caltag). Images were obtained using an Olympus FV1000 confocal microscope (Carsen Group, Markham, ON) with Fluoview software.</p>
      </sec>
      <sec>
        <title>Western Blot</title>
        <p>Cells were lysed in 1% Triton X-100 for 20 min. Lysate was centrifuged for 5 min at 1000 g to eliminate non-solubilized material. Before loading on gels remaining lysate was diluted 2-fold with Laemmli buffer (BioRad), 2% 2-mercaptoethanol was added and samples were boiled for 5 min. Similar amounts of cell lysate (1â1.5 Ã 10<sup>6 </sup>cell equivalents) were loaded per lane on 4â20% SDS-PAGE denaturing gels (Bio-Rad Readygel). Wet protein transfers to PVDF were performed at 100 V for 1 h. PVDF was blocked for 1 h with 5% milk in TBS, 0.1% Tween-20 and subsequently blotted with 0.2 Î¼g/mL primary antibody.</p>
      </sec>
      <sec>
        <title>RT-PCR</title>
        <p>Total RNA was isolated using the Qiagen RNeasy kit. RNA was reverse-transcribed with Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA) using oligo(dT) as primers. The cDNA concentration was estimated by absorbance for each sample and diluted to 100 ng/25 ul of reaction volume. The number of cycles was optimized to be in the exponential phase of the reaction by performing the reaction at different cycles. Densitometric analysis of the gels was performed to select optimal PCR cycle numbers. Thereafter, PCR was performed in 20 Î¼l reactions with primer pairs (25 Î¼M) below. Intron-spanning primers of the sequence 5'-TTTCGGCGAGATACGTCTAACCCTGTGC-3' and 5'-TTTAGCCTCCCCCTTTGTAAAACGGGCG-3' were used to generate a CD8Î± cDNA fragment of 379 bp [<xref ref-type="bibr" rid="B70">70</xref>]. Intron-spanning primers generating a 209 bp product for CD8Î² were 5'-GGTGAAGAGGTGGAACAGGA-3' and 5'-CTTGAGGGTGGACTTCTTGG-3'. A Î²-actin cDNA fragment of 326 bp was produced using intron-spanning primers of sequence 5'-GGC ATC CTC ACC CTG AAG TA-3' and 5'-AGG GCA TAC CCC TCG TAG AT-3'. PCR amplification was performed for 35 cycles of 1 min at 94 C, 1 min at 60 C and 2 min at 72 C, and a final cycle of 72 C for 10 min to complete polymerization. PCR products were run on a 1.5% agarose gel containing ethidium bromide. Intron-spanning primers were used and samples were treated with 84 U/Î¼L DNase I before RT-PCR to avoid interference of contaminating DNA in purified RNA.</p>
        <p>Samples used to amplify CD8Î± mRNA were also amplified with intron-spanning CD3Î¶ RT-PCR primers (5'-GCACAGTTGCCGATTACAGA-3' and 5'-GCCACGTCTCTTGTCCAAA-3', 293 base pair product) for 50 cycles, performed as above.</p>
      </sec>
      <sec>
        <title>2-D electrophoresis</title>
        <p>Lymphocytes and monocytes were enriched by collecting non-adherent and adherent cells respectively after 1 h in culture flasks. Lymphocyte and monocyte lysates were prepared using the 2-D cleanup kit (Bio-Rad) and resuspended in IPG strip rehydration buffer (Bio-Rad) with 2% carrier isoelectric point (pI) 3â10 ampholytes (Bio-Rad). Lysates were focused on 7 cm pI 3â10 strips (Bio-Rad).</p>
      </sec>
      <sec>
        <title>Monoclonal antibody affinity chromatography</title>
        <p>OKT8 at 5â10 mg/mL in 0.1 M HEPES pH 7.5 was coupled to pre-washed N-hydroxysuccinimidyl-activated agarose beads (Sigma) at 4 C for 1 h. Remaining active sites were blocked by incubating in the presence of 0.1 mL 1 M ethanolamine pH 8 at 4 C for 1 h. Rat cultured mast cell line (RCMC, MHC class I purification) or human thymus (CD8 purification) was lysed with 1% triton X-100 in PBS with Complete Mini anti-protease cocktail tablets (Roche Applied Science, Laval, PQ, Canada). Supernatant remaining after 1000 g, 12,000 g, and 100,000 g centrifugations was loaded on columns. Columns were sequentially washed with 30 volumes lysis buffer, 20 volumes 10 mM Tris 0.5% triton X-100 300 mM NaCl pH 8, 20 volumes 10 mM sodium phosphate 0.5% triton X-100 450 mM NaCl pH 10, and eluted with 0.05 M diethylamine 0.5% triton X-100 650 mM NaCl pH 11.5. 1.5 mL fractions were collected into 50 Î¼L 1 M Tris HCl pH 6.7.</p>
      </sec>
      <sec>
        <title>MALDI-QTOF</title>
        <p>Bands were excised and an automated in-gel tryptic digestion was performed on a Mass Prep Station (Water, USA). The gel pieces were de-stained, reduced (DTT), alkylated (Iodoacetamide), digested with trypsin (Promega Sequencing Grade Modified) and the resulting peptides extracted from the gel and analyzed via LC/MS/MS. LC/MS/MS was performed on a CapLC HPLC (Waters, USA) coupled with a Q-ToF-2 mass spectrometer (Waters, USA). Tryptic peptides were separated using a linear water/acetonitrile gradient (0.2% Formic acid) on a Picofrit reversed-phase capillary column, (5 micron BioBasic C18, 300 Angstrom pore size, 75 micron ID Ã 10 cm, 15 micron tip) (New Objectives, MA, USA), with an in-line PepMap column (C18, 300 micron ID Ã 5 mm), (LC Packings, CA, USA) used as a loading/desalting column. Protein identification from the generated MS/MS data was done searching the NCBI non-redundant database using Mascot Daemon (Matrix Science, UK). Search parameters included carbamidomethylation of cysteine, possible oxidation of methionine and one missed cleavage per peptide.</p>
      </sec>
      <sec>
        <title>MHC class I binding</title>
        <p>PE labeled HLA-A*0201 tetramers assembled [<xref ref-type="bibr" rid="B71">71</xref>] with two peptides selected by the SYFPEITHI search engine, <italic>Mycobacterium tuberculosis </italic>antigen 85-B 143â152 (KLVANNTRL) and a diabetes-specific epitope of glutamic acid decarboxylase 114â123 (VMNILLQYVV) were a gift of Dr. John Elliott (University of Alberta). All washes and incubations of cells were done in ice cold PBS with 0.02% NaN<sub>3</sub>. 1 Ã 10<sup>6 </sup>human PBMC were incubated 15 min with 1.5 Î¼g tetramers before the addition of CD14-FITC for 15 min. Before flow cytometry analysis cells were washed three times. In some experiments cells were incubated with 40 Î¼g/mL anti-CD8Î± mAb or isotype control for 30 min prior to addition of tetramers.</p>
      </sec>
      <sec>
        <title>Immune-Complex Stimulation of Monocytes and TNF Measurements</title>
        <p>Monocytes were treated with isotype or anti-CD8Î± mAb (10 Î¼g/mL), or immune-complexes. All mAb were negative for endotoxin using the LAL assay (Sigma-Aldrich). Immune-complexes were prepared by combining isotype mAb or anti-CD8Î± mAb (10 Î¼g/mL) with anti-mouse Ig (20 Î¼g/mL) for 15 min before addition to monocytes. Monocytes enriched on a Percoll gradient were incubated with immune-complexes for 5 h at 0.2 Ã 10<sup>6 </sup>cells/well of a 96 well plate (Becton Dickinson, 35172). Anti-human TNF-PE mAb, fixation and permeabilization buffers, and monensin were from ebioscience (San Diego, CA). Intracellular TNF was detected according to supplier recommendations. Monensin (2 Î¼M) was added 2 h after immune-complexes.</p>
        <p>Stimulation of monocytes with immune-complexes was inhibited by pretreating monocytes with 50 Î¼g/mL purified mouse IgG Fc fragment (Jackson Immunoresearch, West Grove, USA) to block binding of immune-complexes to FcR. In these experiments free binding sites of anti-mouse Ig antibody in immune-complexes that might otherwise bind Fc fragments on pretreated monocytes, were pre-blocked with 50 Î¼g/mL purified Fc fragment.</p>
        <p>TNF release was measured by ELISA after activation of monocytes for 18 h using 2 Î¼g/mL anti-human TNF mAb as a capture antibody (clone 28401, R&amp;D Systems, Minneapolis, MN) and biotinylated anti-human TNF (BAF210, R&amp;D systems) as a detection antibody. Signal was detected with streptavidin-HRP (Vector Labs, Burlingame, CA) and <italic>o</italic>-phenylenediamine.</p>
      </sec>
      <sec>
        <title>Measurement of CD14 and CD69 Expression</title>
        <p>After 18 h activation cells were stained with CD14-FITC/CD69-PE or isotype controls and fixed (ebioscience fixation buffer) before analysis on a FACScan.</p>
      </sec>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>AM (alveolar macrophage), MÏ (macrophage), geometric mean (Gm), immunoglobulin-like-transcript (ILT), isoelectric point (pI), Linker for Activation of T cells (LAT), peripheral blood mononuclear cell (PBMC)</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>DG designed and analyzed experiments, wrote the manuscript and performed flow cytometry, western blots, 2-D electrophoresis, confocal microscopy, MHC binding and monocyte activation assays. MMP helped perform confocal microscopy and designed, performed and analyzed RT-PCR results for CD8Î² and CD3Î¶. YS performed 2D blots with polyclonal antibodies and analyzed results. MCYN performed RT-PCR for CD8Î± and some flow cytometry and western blot. ADB designed and analyzed experiments, revised and approved this document. All authors read and approved the final manuscript.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="S1">
        <caption>
          <title>Additional file 1</title>
          <p>Protein recognized by anti-CD8Î± mAb D9 is CD8Î±. CD8Î± was enriched from human thymus lysate by immunoaffinity chromatography with anti-CD8Î± mAb OKT8. OKT8-reactive fractions were analyzed by western blot with anti-CD8Î± mAb D9 (left), and silver stain (right) after 2-D electrophoresis. Alignment of western blot and silver stain gels allowed extraction of D9-reactive spots from silver stained gels for peptide sequencing by MALDI-QTOF (lower panel).</p>
        </caption>
        <media xlink:href="1471-2172-8-12-S1.ppt" mimetype="application" mime-subtype="vnd.ms-powerpoint">
          <caption>
            <p>Click here for file</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>Supported by Canadian Institutes of Health Research (CIHR) and Alberta Lung Association operating grants (ADB), an Alberta Lung Association Studentship award to DG and summer studentship award (MN) from the Alberta Heritage Foundation for Medical Research</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ledbetter</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Lipinski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cunningham-Rundles</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Good</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Herzenberg</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man</article-title>
          <source>J Exp Med</source>
          <year>1981</year>
          <volume>153</volume>
          <fpage>310</fpage>
          <lpage>323</lpage>
          <pub-id pub-id-type="pmid">6165796</pub-id>
          <pub-id pub-id-type="doi">10.1084/jem.153.2.310</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bosselut</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Ashe</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Kopacz</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Samelson</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Singer</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Association of the adaptor molecule LAT with CD4 and CD8 coreceptors identifies a new coreceptor function in T cell receptor signal transduction</article-title>
          <source>J Exp Med</source>
          <year>1999</year>
          <volume>190</volume>
          <fpage>1517</fpage>
          <lpage>1526</lpage>
          <pub-id pub-id-type="pmid">10562325</pub-id>
          <pub-id pub-id-type="doi">10.1084/jem.190.10.1517</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Janeway</surname>
              <given-names>CA</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation</article-title>
          <source>Annu Rev Immunol</source>
          <year>1992</year>
          <volume>10</volume>
          <fpage>645</fpage>
          <lpage>674</lpage>
          <pub-id pub-id-type="pmid">1534242</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thome</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Duplay</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Guttinger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Acuto</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta complex</article-title>
          <source>J Exp Med</source>
          <year>1995</year>
          <fpage>1997</fpage>
          <lpage>2006</lpage>
          <pub-id pub-id-type="pmid">7539035</pub-id>
          <pub-id pub-id-type="doi">10.1084/jem.181.6.1997</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thome</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Germain</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>DiSanto</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Acuto</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>The p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated T cell receptor/CD3/zeta complex</article-title>
          <source>Eur J Immunol</source>
          <year>1996</year>
          <fpage>2093</fpage>
          <lpage>2100</lpage>
          <pub-id pub-id-type="pmid">8814252</pub-id>
          <pub-id pub-id-type="doi">10.1002/eji.1830260920</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miceli</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>von Hoegen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Parnes</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Adhesion versus coreceptor function of CD4 and CD8: role of the cytoplasmic tail in coreceptor activity</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1991</year>
          <volume>88</volume>
          <fpage>2623</fpage>
          <lpage>2627</lpage>
          <pub-id pub-id-type="pmid">1901411</pub-id>
          <pub-id pub-id-type="doi">10.1073/pnas.88.7.2623</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Glaichenhaus</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shastri</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Littman</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells</article-title>
          <source>Cell</source>
          <year>1991</year>
          <volume>64</volume>
          <fpage>511</fpage>
          <lpage>520</lpage>
          <pub-id pub-id-type="pmid">1671341</pub-id>
          <pub-id pub-id-type="doi">10.1016/0092-8674(91)90235-Q</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Winkel</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sotzik</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Vremec</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cameron</surname>
              <given-names>PU</given-names>
            </name>
            <name>
              <surname>Shortman</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>CD4 and CD8 expression by human and mouse thymic dendritic cells</article-title>
          <source>Immunol Lett</source>
          <year>1994</year>
          <fpage>93</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="pmid">8088877</pub-id>
          <pub-id pub-id-type="doi">10.1016/0165-2478(94)90178-3</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perussia</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fanning</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Trinchieri</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8</article-title>
          <source>J Immunol</source>
          <year>1983</year>
          <volume>131</volume>
          <fpage>223</fpage>
          <lpage>231</lpage>
          <pub-id pub-id-type="pmid">6408172</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moebius</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Kober</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Griscelli</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Hercend</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Meuer</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Expression of different CD8 isoforms on distinct human lymphocyte subpopulations</article-title>
          <source>Eur J Immunol</source>
          <year>1991</year>
          <volume>21</volume>
          <fpage>1793</fpage>
          <lpage>1800</lpage>
          <pub-id pub-id-type="pmid">1831127</pub-id>
          <pub-id pub-id-type="doi">10.1002/eji.1830210803</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Hirji</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nohara</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Stenton</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Gilchrist</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Befus</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
          <article-title>Mast cells express novel CD8 molecules that selectively modulate mediator secretion</article-title>
          <source>J Immunol</source>
          <year>1998</year>
          <volume>161</volume>
          <fpage>6265</fpage>
          <lpage>6272</lpage>
          <pub-id pub-id-type="pmid">9834115</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirji</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Befus</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
          <article-title>A novel CD8 molecule expressed by alveolar and peritoneal macrophages stimulates nitric oxide production</article-title>
          <source>J Immunol</source>
          <year>1997</year>
          <volume>158</volume>
          <fpage>1833</fpage>
          <lpage>1840</lpage>
          <pub-id pub-id-type="pmid">9029123</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davis</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Dennis</surname>
              <given-names>G</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Odom</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Kimberly</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Burrows</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family</article-title>
          <source>Immunol Rev</source>
          <year>2002</year>
          <volume>190</volume>
          <fpage>123</fpage>
          <lpage>136</lpage>
          <pub-id pub-id-type="pmid">12493010</pub-id>
          <pub-id pub-id-type="doi">10.1034/j.1600-065X.2002.19009.x</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moretta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bottino</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vitale</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pende</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cantoni</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mingari</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Biassoni</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Moretta</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis</article-title>
          <source>Annu Rev Immunol</source>
          <year>2001</year>
          <volume>19</volume>
          <fpage>197</fpage>
          <lpage>223</lpage>
          <pub-id pub-id-type="pmid">11244035</pub-id>
          <pub-id pub-id-type="doi">10.1146/annurev.immunol.19.1.197</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakajima</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Samaridis</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Angman</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Colonna</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain</article-title>
          <source>J Immunol</source>
          <year>1999</year>
          <fpage>5</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">9886363</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petersson</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ivars</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Early TCR alpha beta expression promotes maturation of T cells expressing Fc epsilon RI gamma containing TCR/CD3 complexes</article-title>
          <source>J Immunol</source>
          <year>2001</year>
          <volume>166</volume>
          <fpage>6616</fpage>
          <lpage>6624</lpage>
          <pub-id pub-id-type="pmid">11359815</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>She</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Simpson</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hollander</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Levelt</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>van Houten</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Terhorst</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>CD16-expressing CD8alpha alpha+ T lymphocytes in the intestinal epithelium: possible precursors of Fc gammaR-CD8alpha alpha+ T cells</article-title>
          <source>J Immunol</source>
          <year>1997</year>
          <volume>158</volume>
          <fpage>4678</fpage>
          <lpage>4687</lpage>
          <pub-id pub-id-type="pmid">9144480</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qian</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sperling</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Lancki</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Tatsumi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Barrett</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Bluestone</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Fitch</surname>
              <given-names>FW</given-names>
            </name>
          </person-group>
          <article-title>The gamma chain of the high-affinity receptor for IgE is a major functional subunit of the T-cell antigen receptor complex in gamma delta T lymphocytes</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1993</year>
          <volume>90</volume>
          <fpage>11875</fpage>
          <lpage>11879</lpage>
          <pub-id pub-id-type="pmid">8265641</pub-id>
          <pub-id pub-id-type="doi">10.1073/pnas.90.24.11875</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kappler</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Marrack</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Development and function of T cells in T cell antigen receptor/CD3 zeta knockout mice reconstituted with Fc epsilon RI gamma</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1997</year>
          <volume>94</volume>
          <fpage>616</fpage>
          <lpage>621</lpage>
          <pub-id pub-id-type="pmid">9012833</pub-id>
          <pub-id pub-id-type="doi">10.1073/pnas.94.2.616</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodewald</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Arulanandam</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Koyasu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Reinherz</surname>
              <given-names>EL</given-names>
            </name>
          </person-group>
          <article-title>The high affinity Fc epsilon receptor gamma subunit (Fc epsilon RI gamma) facilitates T cell receptor expression and antigen/major histocompatibility complex-driven signaling in the absence of CD3 zeta and CD3 eta</article-title>
          <source>J Biol Chem</source>
          <year>1991</year>
          <volume>266</volume>
          <fpage>15974</fpage>
          <lpage>15978</lpage>
          <pub-id pub-id-type="pmid">1714902</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Howard</surname>
              <given-names>FD</given-names>
            </name>
            <name>
              <surname>Rodewald</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Kinet</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Reinherz</surname>
              <given-names>EL</given-names>
            </name>
          </person-group>
          <article-title>CD3 zeta subunit can substitute for the gamma subunit of Fc epsilon receptor type I in assembly and functional expression of the high-affinity IgE receptor: evidence for interreceptor complementation</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1990</year>
          <volume>87</volume>
          <fpage>7015</fpage>
          <lpage>7019</lpage>
          <pub-id pub-id-type="pmid">1698288</pub-id>
          <pub-id pub-id-type="doi">10.1073/pnas.87.18.7015</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ra</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jouvin</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Blank</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Kinet</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>A macrophage Fc gamma receptor and the mast cell receptor for IgE share an identical subunit</article-title>
          <source>Nature</source>
          <year>1989</year>
          <volume>341</volume>
          <fpage>752</fpage>
          <lpage>754</lpage>
          <pub-id pub-id-type="pmid">2529442</pub-id>
          <pub-id pub-id-type="doi">10.1038/341752a0</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krishnan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Warke</surname>
              <given-names>VG</given-names>
            </name>
            <name>
              <surname>Nambiar</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Tsokos</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Farber</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>The FcR gamma subunit and Syk kinase replace the CD3 zeta-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells</article-title>
          <source>J Immunol</source>
          <year>2003</year>
          <volume>170</volume>
          <fpage>4189</fpage>
          <lpage>4195</lpage>
          <pub-id pub-id-type="pmid">12682251</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chu</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>van Oers</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Malissen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Elder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Pre-T cell receptor signals are responsible for the down-regulation of Syk protein tyrosine kinase expression</article-title>
          <source>J Immunol</source>
          <year>1999</year>
          <volume>163</volume>
          <fpage>2610</fpage>
          <lpage>2620</lpage>
          <pub-id pub-id-type="pmid">10453000</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kieffer</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Cunningham</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Gladue</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>McNeish</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kavathas</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Hanke</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Human CD8 alpha expression in NK cells but not cytotoxic T cells of transgenic mice</article-title>
          <source>Int Immunol</source>
          <year>1996</year>
          <volume>8</volume>
          <fpage>1617</fpage>
          <lpage>1626</lpage>
          <pub-id pub-id-type="pmid">8921442</pub-id>
          <pub-id pub-id-type="doi">10.1093/intimm/8.10.1617</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leon</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>dH</given-names>
            </name>
            <name>
              <surname>Parrillas</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Vargas</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Sanchez-Mateos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Longo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lopes-Bravo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ardavin</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8- and CD8+ splenic dendritic cells</article-title>
          <source>Blood</source>
          <year>2004</year>
          <volume>103</volume>
          <fpage>2668</fpage>
          <lpage>2676</lpage>
          <pub-id pub-id-type="pmid">14630812</pub-id>
          <pub-id pub-id-type="doi">10.1182/blood-2003-01-0286</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Nault</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Expression of CD8 on mouse alveolar macrophages</article-title>
          <source>Thesis (MSc)</source>
          <year>2003</year>
          <publisher-name>Edmonton, Alberta, University of Alberta</publisher-name>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vremec</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pooley</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hochrein</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Shortman</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen</article-title>
          <source>J Immunol</source>
          <year>2000</year>
          <volume>164</volume>
          <fpage>2978</fpage>
          <lpage>2986</lpage>
          <pub-id pub-id-type="pmid">10706685</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baba</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ishizu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Iwasaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tomaru</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Ikeda</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yoshiki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kasahara</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>CD4+/CD8+ macrophages infiltrating at inflammatory sites: a population of monocytes/macrophages with a cytotoxic phenotype</article-title>
          <source>Blood</source>
          <year>2006</year>
          <volume>107</volume>
          <fpage>2004</fpage>
          <lpage>2012</lpage>
          <pub-id pub-id-type="pmid">16269616</pub-id>
          <pub-id pub-id-type="doi">10.1182/blood-2005-06-2345</pub-id>
        </citation>
      </ref>
      <ref id="B30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Lei</surname>
              <given-names>HY</given-names>
            </name>
          </person-group>
          <article-title>Transient CD4/CD8 ratio inversion and aberrant immune activation during dengue virus infection</article-title>
          <source>J Med Virol</source>
          <year>2002</year>
          <volume>68</volume>
          <fpage>241</fpage>
          <lpage>252</lpage>
          <pub-id pub-id-type="pmid">12210415</pub-id>
          <pub-id pub-id-type="doi">10.1002/jmv.10198</pub-id>
        </citation>
      </ref>
      <ref id="B31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grage-Griebenow</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Flad</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Ernst</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Heterogeneity of human peripheral blood monocyte subsets</article-title>
          <source>J Leukoc Biol</source>
          <year>2001</year>
          <volume>69</volume>
          <fpage>11</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">11200054</pub-id>
        </citation>
      </ref>
      <ref id="B32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Devine</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kieffer</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Aitken</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Kavathas</surname>
              <given-names>PB</given-names>
            </name>
          </person-group>
          <article-title>Human CD8 beta, but not mouse CD8 beta, can be expressed in the absence of CD8 alpha as a beta beta homodimer</article-title>
          <source>J Immunol</source>
          <year>2000</year>
          <fpage>833</fpage>
          <lpage>838</lpage>
          <pub-id pub-id-type="pmid">10623829</pub-id>
        </citation>
      </ref>
      <ref id="B33">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ravetch</surname>
              <given-names>JV</given-names>
            </name>
            <name>
              <surname>Bolland</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>IgG Fc receptors</article-title>
          <source>Annu Rev Immunol</source>
          <year>2001</year>
          <volume>19</volume>
          <fpage>275</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="pmid">11244038</pub-id>
          <pub-id pub-id-type="doi">10.1146/annurev.immunol.19.1.275</pub-id>
        </citation>
      </ref>
      <ref id="B34">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nimmerjahn</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ravetch</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Fcgamma Receptors: Old Friends and New Family Members</article-title>
          <source>Immunity</source>
          <year>2006</year>
          <volume>24</volume>
          <fpage>19</fpage>
          <lpage>28</lpage>
          <pub-id pub-id-type="pmid">16413920</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.immuni.2005.11.010</pub-id>
        </citation>
      </ref>
      <ref id="B35">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubeck</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Steplewski</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Baglia</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Dorrington</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Koprowski</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The interaction of murine IgG subclass proteins with human monocyte Fc receptors</article-title>
          <source>J Immunol</source>
          <year>1985</year>
          <volume>135</volume>
          <fpage>1299</fpage>
          <lpage>1304</lpage>
          <pub-id pub-id-type="pmid">3159790</pub-id>
        </citation>
      </ref>
      <ref id="B36">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubeck</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Steplewski</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Baglia</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Dorrington</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Koprowski</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The interaction of murine IgG subclass proteins with human monocyte Fc receptors</article-title>
          <source>J Immunol</source>
          <year>1985</year>
          <volume>135</volume>
          <fpage>1299</fpage>
          <lpage>1304</lpage>
          <pub-id pub-id-type="pmid">3159790</pub-id>
        </citation>
      </ref>
      <ref id="B37">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Looney</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>Two distinct classes of IgG Fc receptors on a human monocyte line (U937) defined by differences in binding of murine IgG subclasses at low ionic strength</article-title>
          <source>J Immunol</source>
          <year>1985</year>
          <volume>135</volume>
          <fpage>3348</fpage>
          <lpage>3353</lpage>
          <pub-id pub-id-type="pmid">2931481</pub-id>
        </citation>
      </ref>
      <ref id="B38">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dougherty</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Selvendran</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Murdoch</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Palmer</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Hogg</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>The human mononuclear phagocyte high-affinity Fc receptor, FcRI, defined by a monoclonal antibody, 10.1</article-title>
          <source>Eur J Immunol</source>
          <year>1987</year>
          <volume>17</volume>
          <fpage>1453</fpage>
          <lpage>1459</lpage>
          <pub-id pub-id-type="pmid">3500057</pub-id>
          <pub-id pub-id-type="doi">10.1002/eji.1830171011</pub-id>
        </citation>
      </ref>
      <ref id="B39">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spaggiari</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Contini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Carosio</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Arvigo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ghio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Oddone</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dondero</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zocchi</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Puppo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Indiveri</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Poggi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily</article-title>
          <source>Blood</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>1706</fpage>
          <lpage>1714</lpage>
          <pub-id pub-id-type="pmid">11861287</pub-id>
          <pub-id pub-id-type="doi">10.1182/blood.V99.5.1706</pub-id>
        </citation>
      </ref>
      <ref id="B40">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chapman</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Heikema</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>AP</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Bjorkman</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2)</article-title>
          <source>Immunity</source>
          <year>2000</year>
          <volume>13</volume>
          <fpage>727</fpage>
          <lpage>736</lpage>
          <pub-id pub-id-type="pmid">11114384</pub-id>
          <pub-id pub-id-type="doi">10.1016/S1074-7613(00)00071-6</pub-id>
        </citation>
      </ref>
      <ref id="B41">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bosselut</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kubo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Guinter</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kopacz</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Altman</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Feigenbaum</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Singer</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Role of CD8beta domains in CD8 coreceptor function: importance for MHC I binding, signaling, and positive selection of CD8+ T cells in the thymus</article-title>
          <source>Immunity</source>
          <year>2000</year>
          <fpage>409</fpage>
          <lpage>418</lpage>
          <pub-id pub-id-type="pmid">10795739</pub-id>
          <pub-id pub-id-type="doi">10.1016/S1074-7613(00)80193-4</pub-id>
        </citation>
      </ref>
      <ref id="B42">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Daniels</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Devine</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Moser</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Lukacher</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Altman</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Kavathas</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hogquist</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Jameson</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation</article-title>
          <source>Immunity</source>
          <year>2001</year>
          <volume>15</volume>
          <fpage>1051</fpage>
          <lpage>1061</lpage>
          <pub-id pub-id-type="pmid">11754824</pub-id>
          <pub-id pub-id-type="doi">10.1016/S1074-7613(01)00252-7</pub-id>
        </citation>
      </ref>
      <ref id="B43">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moody</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Chui</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Reche</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Priatel</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Marth</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Reinherz</surname>
              <given-names>EL</given-names>
            </name>
          </person-group>
          <article-title>Developmentally regulated glycosylation of the CD8alphabeta coreceptor stalk modulates ligand binding</article-title>
          <source>Cell</source>
          <year>2001</year>
          <volume>107</volume>
          <fpage>501</fpage>
          <lpage>512</lpage>
          <pub-id pub-id-type="pmid">11719190</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0092-8674(01)00577-3</pub-id>
        </citation>
      </ref>
      <ref id="B44">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maeurer</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Necker</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Salter</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Castelli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hohn</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Karbach</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Freitag</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Neukirch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Knuth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jager</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogue</article-title>
          <source>Int J Cancer</source>
          <year>2002</year>
          <volume>97</volume>
          <fpage>64</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="pmid">11774245</pub-id>
          <pub-id pub-id-type="doi">10.1002/ijc.1580</pub-id>
        </citation>
      </ref>
      <ref id="B45">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuball</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schmitz</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Voss</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Engel</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Guillaume</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Strand</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Huber</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sherman</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Theobald</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cooperation of human tumor-reactive CD4+ and CD8+ T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR</article-title>
          <source>Immunity</source>
          <year>2005</year>
          <volume>22</volume>
          <fpage>117</fpage>
          <lpage>129</lpage>
          <pub-id pub-id-type="pmid">15664164</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.immuni.2004.12.005</pub-id>
        </citation>
      </ref>
      <ref id="B46">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Campanelli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Palermo</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Garbelli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mantovani</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lucchi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Necker</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lantelme</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Giachino</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Human CD8 co-receptor is strictly involved in MHC-peptide tetramer-TCR binding and T cell activation</article-title>
          <source>Int Immunol</source>
          <year>2002</year>
          <volume>14</volume>
          <fpage>39</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">11751750</pub-id>
          <pub-id pub-id-type="doi">10.1093/intimm/14.1.39</pub-id>
        </citation>
      </ref>
      <ref id="B47">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pittet</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Rubio-Godoy</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bioley</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Guillaume</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Batard</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Speiser</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Luescher</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Cerottini</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Zippelius</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells</article-title>
          <source>J Immunol</source>
          <year>2003</year>
          <volume>171</volume>
          <fpage>1844</fpage>
          <lpage>1849</lpage>
          <pub-id pub-id-type="pmid">12902485</pub-id>
        </citation>
      </ref>
      <ref id="B48">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Snow</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Van de</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Terhorst</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Association between the human thymic differentiation antigens T6 and T8</article-title>
          <source>Eur J Immunol</source>
          <year>1985</year>
          <volume>15</volume>
          <fpage>529</fpage>
          <lpage>532</lpage>
          <pub-id pub-id-type="pmid">3922774</pub-id>
          <pub-id pub-id-type="doi">10.1002/eji.1830150520</pub-id>
        </citation>
      </ref>
      <ref id="B49">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barber</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Dasgupta</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Schlossman</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Trevillyan</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Rudd</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1989</year>
          <volume>86</volume>
          <fpage>3277</fpage>
          <lpage>3281</lpage>
          <pub-id pub-id-type="pmid">2470098</pub-id>
          <pub-id pub-id-type="doi">10.1073/pnas.86.9.3277</pub-id>
        </citation>
      </ref>
      <ref id="B50">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Snow</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Keizer</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Coligan</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Terhorst</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Purification and N-terminal amino acid sequence of the human T cell surface antigen T8</article-title>
          <source>J Immunol</source>
          <year>1984</year>
          <volume>133</volume>
          <fpage>2058</fpage>
          <lpage>2066</lpage>
          <pub-id pub-id-type="pmid">6381594</pub-id>
        </citation>
      </ref>
      <ref id="B51">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pichler</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Wolff-Vorbeck</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Birke</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rieber</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Peter</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>Comparison of the inhibitory activity of seven anti-T8 antibodies on specific cellular cytotoxicity</article-title>
          <source>Immunobiology</source>
          <year>1984</year>
          <volume>167</volume>
          <fpage>376</fpage>
          <lpage>388</lpage>
          <pub-id pub-id-type="pmid">6210245</pub-id>
        </citation>
      </ref>
      <ref id="B52">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Biddison</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Talle</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Boselli</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Distinct epitopes on the T8 molecule are differentially involved in cytotoxic T cell function</article-title>
          <source>Hum Immunol</source>
          <year>1984</year>
          <volume>9</volume>
          <fpage>117</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="pmid">6199334</pub-id>
          <pub-id pub-id-type="doi">10.1016/0198-8859(84)90034-X</pub-id>
        </citation>
      </ref>
      <ref id="B53">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Seventer</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Van Lier</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Spits</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ivanyi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Melief</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones</article-title>
          <source>Eur J Immunol</source>
          <year>1986</year>
          <volume>16</volume>
          <fpage>1363</fpage>
          <lpage>1371</lpage>
          <pub-id pub-id-type="pmid">2430810</pub-id>
          <pub-id pub-id-type="doi">10.1002/eji.1830161109</pub-id>
        </citation>
      </ref>
      <ref id="B54">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fridlender</surname>
              <given-names>ZG</given-names>
            </name>
            <name>
              <surname>Rabinowitz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schlesinger</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Monocytes confer CD14 antigenicity on activated lymphocytes</article-title>
          <source>Hum Immunol</source>
          <year>1999</year>
          <volume>60</volume>
          <fpage>1028</fpage>
          <lpage>1038</lpage>
          <pub-id pub-id-type="pmid">10599999</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0198-8859(99)00110-X</pub-id>
        </citation>
      </ref>
      <ref id="B55">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tartakovsky</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fried</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bleiberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yust</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>An intracellular antigen that reacts with MO2, a monoclonal antibody to CD14, is expressed by human lymphocytes</article-title>
          <source>Immunol Lett</source>
          <year>2003</year>
          <volume>85</volume>
          <fpage>35</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">12505194</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0165-2478(02)00199-2</pub-id>
        </citation>
      </ref>
      <ref id="B56">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pascale</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Malagolini</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Serafini-Cessi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Migliaccio</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Leone</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bonatti</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Biosynthesis and oligosaccharide structure of human CD8 glycoprotein expressed in a rat epithelial cell line</article-title>
          <source>J Biol Chem</source>
          <year>1992</year>
          <volume>267</volume>
          <fpage>9940</fpage>
          <lpage>9947</lpage>
          <pub-id pub-id-type="pmid">1577825</pub-id>
        </citation>
      </ref>
      <ref id="B57">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>ten Brinke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vaandrager</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Haagsman</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Ridder</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>van Golde</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Batenburg</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Structural requirements for palmitoylation of surfactant protein C precursor</article-title>
          <source>Biochem J</source>
          <year>2002</year>
          <volume>361</volume>
          <fpage>663</fpage>
          <lpage>671</lpage>
          <pub-id pub-id-type="pmid">11802797</pub-id>
          <pub-id pub-id-type="doi">10.1042/0264-6021:3610663</pub-id>
        </citation>
      </ref>
      <ref id="B58">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Harley</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Punt</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Sharrow</surname>
              <given-names>SO</given-names>
            </name>
            <name>
              <surname>Kearse</surname>
              <given-names>KP</given-names>
            </name>
          </person-group>
          <article-title>Identification of CD8 as a peanut agglutinin (PNA) receptor molecule on immature thymocytes</article-title>
          <source>J Exp Med</source>
          <year>1996</year>
          <volume>184</volume>
          <fpage>759</fpage>
          <lpage>764</lpage>
          <pub-id pub-id-type="pmid">8760831</pub-id>
          <pub-id pub-id-type="doi">10.1084/jem.184.2.759</pub-id>
        </citation>
      </ref>
      <ref id="B59">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arcaro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gregoire</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Baldi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Goffin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Boucheron</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wurm</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>van der Merwe</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Malissen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Luescher</surname>
              <given-names>IF</given-names>
            </name>
          </person-group>
          <article-title>CD8beta endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes</article-title>
          <source>J Exp Med</source>
          <year>2001</year>
          <volume>194</volume>
          <fpage>1485</fpage>
          <lpage>1495</lpage>
          <pub-id pub-id-type="pmid">11714755</pub-id>
          <pub-id pub-id-type="doi">10.1084/jem.194.10.1485</pub-id>
        </citation>
      </ref>
      <ref id="B60">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vremec</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shortman</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes</article-title>
          <source>J Immunol</source>
          <year>1997</year>
          <fpage>565</fpage>
          <lpage>573</lpage>
          <pub-id pub-id-type="pmid">9218570</pub-id>
        </citation>
      </ref>
      <ref id="B61">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vremec</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zorbas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Scollay</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Saunders</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Ardavin</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Shortman</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells</article-title>
          <source>J Exp Med</source>
          <year>1992</year>
          <volume>176</volume>
          <fpage>47</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="pmid">1613465</pub-id>
          <pub-id pub-id-type="doi">10.1084/jem.176.1.47</pub-id>
        </citation>
      </ref>
      <ref id="B62">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leishman</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Naidenko</surname>
              <given-names>OV</given-names>
            </name>
            <name>
              <surname>Attinger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Koning</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lena</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Reinherz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kronenberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cheroutre</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>T cell responses modulated through interaction between CD8alphaalpha and the nonclassical MHC class I molecule, TL</article-title>
          <source>Science</source>
          <year>2001</year>
          <fpage>1936</fpage>
          <lpage>1939</lpage>
          <pub-id pub-id-type="pmid">11729321</pub-id>
          <pub-id pub-id-type="doi">10.1126/science.1063564</pub-id>
        </citation>
      </ref>
      <ref id="B63">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gangadharan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cheroutre</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The CD8 isoform CD8alphaalpha is not a functional homologue of the TCR co-receptor CD8alphabeta</article-title>
          <source>Curr Opin Immunol</source>
          <year>2004</year>
          <volume>16</volume>
          <fpage>264</fpage>
          <lpage>270</lpage>
          <pub-id pub-id-type="pmid">15134773</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.coi.2004.03.015</pub-id>
        </citation>
      </ref>
      <ref id="B64">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Romero</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cerottini</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Luescher</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>On the significance of CD8alphaalpha expression for T cell memory</article-title>
          <source>Eur J Immunol</source>
          <year>2005</year>
          <volume>35</volume>
          <fpage>3092</fpage>
          <lpage>3094</lpage>
          <pub-id pub-id-type="pmid">16276480</pub-id>
          <pub-id pub-id-type="doi">10.1002/eji.200535516</pub-id>
        </citation>
      </ref>
      <ref id="B65">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Madakamutil</surname>
              <given-names>LT</given-names>
            </name>
            <name>
              <surname>Christen</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Lena</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Wang-Zhu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Attinger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sundarrajan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ellmeier</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>von Herrath</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Littman</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Cheroutre</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>CD8alphaalpha-mediated survival and differentiation of CD8 memory T cell precursors</article-title>
          <source>Science</source>
          <year>2004</year>
          <volume>304</volume>
          <fpage>590</fpage>
          <lpage>593</lpage>
          <pub-id pub-id-type="pmid">15105501</pub-id>
          <pub-id pub-id-type="doi">10.1126/science.1092316</pub-id>
        </citation>
      </ref>
      <ref id="B66">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chandele</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kaech</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Cutting edge: memory CD8 T cell maturation occurs independently of CD8alphaalpha</article-title>
          <source>J Immunol</source>
          <year>2005</year>
          <volume>175</volume>
          <fpage>5619</fpage>
          <lpage>5623</lpage>
          <pub-id pub-id-type="pmid">16237050</pub-id>
        </citation>
      </ref>
      <ref id="B67">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhong</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Reinherz</surname>
              <given-names>EL</given-names>
            </name>
          </person-group>
          <article-title>CD8 alpha alpha homodimer expression and role in CD8 T cell memory generation during influenza virus A infection in mice</article-title>
          <source>Eur J Immunol</source>
          <year>2005</year>
          <volume>35</volume>
          <fpage>3103</fpage>
          <lpage>3110</lpage>
          <pub-id pub-id-type="pmid">16231286</pub-id>
          <pub-id pub-id-type="doi">10.1002/eji.200535162</pub-id>
        </citation>
      </ref>
      <ref id="B68">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leishman</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Naidenko</surname>
              <given-names>OV</given-names>
            </name>
            <name>
              <surname>Attinger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Koning</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lena</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Reinherz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kronenberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cheroutre</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>T cell responses modulated through interaction between CD8alphaalpha and the nonclassical MHC class I molecule, TL</article-title>
          <source>Science</source>
          <year>2001</year>
          <fpage>1936</fpage>
          <lpage>1939</lpage>
          <pub-id pub-id-type="pmid">11729321</pub-id>
          <pub-id pub-id-type="doi">10.1126/science.1063564</pub-id>
        </citation>
      </ref>
      <ref id="B69">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gabert</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Langlet</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zamoyska</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Parnes</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Schmitt-Verhulst</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Malissen</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Reconstitution of MHC class I specificity by transfer of the T cell receptor and Lyt-2 genes</article-title>
          <source>Cell</source>
          <year>1987</year>
          <volume>50</volume>
          <fpage>545</fpage>
          <lpage>554</lpage>
          <pub-id pub-id-type="pmid">2955903</pub-id>
          <pub-id pub-id-type="doi">10.1016/0092-8674(87)90027-4</pub-id>
        </citation>
      </ref>
      <ref id="B70">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holler</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Kranz</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation</article-title>
          <source>Immunity</source>
          <year>2003</year>
          <volume>18</volume>
          <fpage>255</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="pmid">12594952</pub-id>
          <pub-id pub-id-type="doi">10.1016/S1074-7613(03)00019-0</pub-id>
        </citation>
      </ref>
      <ref id="B71">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Letourneur</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gabert</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cosson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Blanc</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Davoust</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Malissen</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>A signaling role for the cytoplasmic segment of the CD8 alpha chain detected under limiting stimulatory conditions</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1990</year>
          <volume>87</volume>
          <fpage>2339</fpage>
          <lpage>2343</lpage>
          <pub-id pub-id-type="pmid">2107551</pub-id>
          <pub-id pub-id-type="doi">10.1073/pnas.87.6.2339</pub-id>
        </citation>
      </ref>
      <ref id="B72">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wheeler</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>von Hoegen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Parnes</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>An immunological role for the CD8 beta-chain</article-title>
          <source>Nature</source>
          <year>1992</year>
          <volume>357</volume>
          <fpage>247</fpage>
          <lpage>249</lpage>
          <pub-id pub-id-type="pmid">1534146</pub-id>
          <pub-id pub-id-type="doi">10.1038/357247a0</pub-id>
        </citation>
      </ref>
      <ref id="B73">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zamoyska</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Derham</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gorman</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>von Hoegen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bolen</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Veillette</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Parnes</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Inability of CD8 alpha' polypeptides to associate with p56lck correlates with impaired function in vitro and lack of expression in vivo</article-title>
          <source>Nature</source>
          <year>1989</year>
          <volume>342</volume>
          <fpage>278</fpage>
          <lpage>281</lpage>
          <pub-id pub-id-type="pmid">2509945</pub-id>
          <pub-id pub-id-type="doi">10.1038/342278a0</pub-id>
        </citation>
      </ref>
      <ref id="B74">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chu</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Spits</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Peyron</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Rowley</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Bolen</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The Syk protein tyrosine kinase can function independently of CD45 or Lck in T cell antigen receptor signaling</article-title>
          <source>EMBO J</source>
          <year>1996</year>
          <volume>15</volume>
          <fpage>6251</fpage>
          <lpage>6261</lpage>
          <pub-id pub-id-type="pmid">8947048</pub-id>
        </citation>
      </ref>
      <ref id="B75">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Jahn</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lamkin</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Uribe</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Durden</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Weinberg</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Differential activation of the tyrosine kinases ZAP-70 and Syk after Fc gamma RI stimulation</article-title>
          <source>Blood</source>
          <year>1997</year>
          <volume>89</volume>
          <fpage>388</fpage>
          <lpage>396</lpage>
          <pub-id pub-id-type="pmid">9002939</pub-id>
        </citation>
      </ref>
      <ref id="B76">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tridandapani</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lyden</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Carter</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Coggeshall</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>The adapter protein LAT enhances fcgamma receptor-mediated signal transduction in myeloid cells</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>20480</fpage>
          <lpage>20487</lpage>
          <pub-id pub-id-type="pmid">10781611</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.M909462199</pub-id>
        </citation>
      </ref>
      <ref id="B77">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuster</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kinet</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Characterization and expression of the gene for the human Fc receptor gamma subunit. Definition of a new gene family</article-title>
          <source>J Biol Chem</source>
          <year>1990</year>
          <volume>265</volume>
          <fpage>6448</fpage>
          <lpage>6452</lpage>
          <pub-id pub-id-type="pmid">2138619</pub-id>
        </citation>
      </ref>
      <ref id="B78">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saitoh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Odom</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gomez</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sommers</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Rivera</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Samelson</surname>
              <given-names>LE</given-names>
            </name>
          </person-group>
          <article-title>The four distal tyrosines are required for LAT-dependent signaling in FcepsilonRI-mediated mast cell activation</article-title>
          <source>J Exp Med</source>
          <year>2003</year>
          <volume>198</volume>
          <fpage>831</fpage>
          <lpage>843</lpage>
          <pub-id pub-id-type="pmid">12953098</pub-id>
          <pub-id pub-id-type="doi">10.1084/jem.20030574</pub-id>
        </citation>
      </ref>
      <ref id="B79">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barrett</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Gajewski</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Danielpour</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Beagley</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Bluestone</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Differential function of intestinal intraepithelial lymphocyte subsets</article-title>
          <source>J Immunol</source>
          <year>1992</year>
          <volume>149</volume>
          <fpage>1124</fpage>
          <lpage>1130</lpage>
          <pub-id pub-id-type="pmid">1380032</pub-id>
        </citation>
      </ref>
      <ref id="B80">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirji</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Bissonnette</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Belosevic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Befus</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of macrophage stimulation through CD8: macrophage CD8alpha and CD8beta induce nitric oxide production and associated killing of the parasite Leishmania major</article-title>
          <source>J Immunol</source>
          <year>1998</year>
          <volume>160</volume>
          <fpage>6004</fpage>
          <lpage>6011</lpage>
          <pub-id pub-id-type="pmid">9637515</pub-id>
        </citation>
      </ref>
      <ref id="B81">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Hirji</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Stenton</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Gilchrist</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Grill</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Schreiber</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Befus</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
          <article-title>Activation of macrophage CD8: pharmacological studies of TNF and IL-1 beta production</article-title>
          <source>J Immunol</source>
          <year>2000</year>
          <volume>164</volume>
          <fpage>1783</fpage>
          <lpage>1792</lpage>
          <pub-id pub-id-type="pmid">10657625</pub-id>
        </citation>
      </ref>
      <ref id="B82">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tam</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Morel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Karkar</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Pusey</surname>
              <given-names>CD</given-names>
            </name>
          </person-group>
          <article-title>Development of scarring and renal failure in a rat model of crescentic glomerulonephritis</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>1999</year>
          <volume>14</volume>
          <fpage>1658</fpage>
          <lpage>1666</lpage>
          <pub-id pub-id-type="pmid">10435873</pub-id>
          <pub-id pub-id-type="doi">10.1093/ndt/14.7.1658</pub-id>
        </citation>
      </ref>
      <ref id="B83">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>May</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Dorris</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Satumtira</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Iqbal</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Rehman</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Lightfoot</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Taurog</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>CD8 alpha beta T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats</article-title>
          <source>J Immunol</source>
          <year>2003</year>
          <volume>170</volume>
          <fpage>1099</fpage>
          <lpage>1105</lpage>
          <pub-id pub-id-type="pmid">12517979</pub-id>
        </citation>
      </ref>
      <ref id="B84">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonnotte</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Larmonier</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Favre</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fromentin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Moutet</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gurbuxani</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Solary</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Chauffert</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Identification of tumor-infiltrating macrophages as the killers of tumor cells after immunization in a rat model system</article-title>
          <source>J Immunol</source>
          <year>2001</year>
          <volume>167</volume>
          <fpage>5077</fpage>
          <lpage>5083</lpage>
          <pub-id pub-id-type="pmid">11673517</pub-id>
        </citation>
      </ref>
      <ref id="B85">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schroeter</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stoll</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Weissert</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hartung</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Lassmann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jander</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>CD8+ phagocyte recruitment in rat experimental autoimmune encephalomyelitis: association with inflammatory tissue destruction</article-title>
          <source>Am J Pathol</source>
          <year>2003</year>
          <volume>163</volume>
          <fpage>1517</fpage>
          <lpage>1524</lpage>
          <pub-id pub-id-type="pmid">14507658</pub-id>
        </citation>
      </ref>
      <ref id="B86">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schroeter</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jander</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Huitinga</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Stoll</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>CD8+ phagocytes in focal ischemia of the rat brain: predominant origin from hematogenous macrophages and targeting to areas of pannecrosis</article-title>
          <source>Acta Neuropathol (Berl)</source>
          <year>2001</year>
          <volume>101</volume>
          <fpage>440</fpage>
          <lpage>448</lpage>
          <pub-id pub-id-type="pmid">11484815</pub-id>
        </citation>
      </ref>
      <ref id="B87">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karkar</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pusey</surname>
              <given-names>CD</given-names>
            </name>
          </person-group>
          <article-title>Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>2001</year>
          <volume>16</volume>
          <fpage>518</fpage>
          <lpage>524</lpage>
          <pub-id pub-id-type="pmid">11239025</pub-id>
          <pub-id pub-id-type="doi">10.1093/ndt/16.3.518</pub-id>
        </citation>
      </ref>
      <ref id="B88">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Braun</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Listing</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zink</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Alten</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Golder</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Gromnica-Ihle</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kellner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Krause</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>SÃ¶rensen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zeidler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Thriene</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Sieper</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial</article-title>
          <source>Lancet</source>
          <year>2002</year>
          <volume>359</volume>
          <fpage>1187</fpage>
          <lpage>1193</lpage>
          <pub-id pub-id-type="pmid">11955536</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(02)08215-6</pub-id>
        </citation>
      </ref>
      <ref id="B89">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Paulnock</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <source>Macrophages: Practical Approach</source>
          <year>2000</year>
          <publisher-name>Oxford: Oxford University Press</publisher-name>
          <pub-id pub-id-type="pmid">10811008</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>